Copyright Reports & Markets. All rights reserved.

Global Human Prothrombin Complex Concentrate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Prothrombin Complex Concentrate Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Beriplex
    • 1.3.3 Profilnine
    • 1.3.4 Octaplex
    • 1.3.5 Prothromplex
    • 1.3.6 Cofact
    • 1.3.7 Other
  • 1.4 Market Analysis by Composition
    • 1.4.1 Overview: Global Human Prothrombin Complex Concentrate Consumption Value by Composition: 2021 Versus 2025 Versus 2032
    • 1.4.2 3-Factor PCC
    • 1.4.3 4-Factor PCC
    • 1.4.4 Recombinant Coagulation Complex
    • 1.4.5 Other
  • 1.5 Market Analysis by Manufacturing Process
    • 1.5.1 Overview: Global Human Prothrombin Complex Concentrate Consumption Value by Manufacturing Process: 2021 Versus 2025 Versus 2032
    • 1.5.2 Plasma-Derived
    • 1.5.3 Recombinant Bioengineered
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Human Prothrombin Complex Concentrate Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hemophilia B
    • 1.6.3 Vitamin K Deficiency
    • 1.6.4 Other
  • 1.7 Global Human Prothrombin Complex Concentrate Market Size & Forecast
    • 1.7.1 Global Human Prothrombin Complex Concentrate Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Human Prothrombin Complex Concentrate Sales Quantity (2021-2032)
    • 1.7.3 Global Human Prothrombin Complex Concentrate Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 CSL Behring
    • 2.1.1 CSL Behring Details
    • 2.1.2 CSL Behring Major Business
    • 2.1.3 CSL Behring Human Prothrombin Complex Concentrate Product and Services
    • 2.1.4 CSL Behring Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 CSL Behring Recent Developments/Updates
  • 2.2 Grifols
    • 2.2.1 Grifols Details
    • 2.2.2 Grifols Major Business
    • 2.2.3 Grifols Human Prothrombin Complex Concentrate Product and Services
    • 2.2.4 Grifols Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Grifols Recent Developments/Updates
  • 2.3 Octapharma
    • 2.3.1 Octapharma Details
    • 2.3.2 Octapharma Major Business
    • 2.3.3 Octapharma Human Prothrombin Complex Concentrate Product and Services
    • 2.3.4 Octapharma Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Octapharma Recent Developments/Updates
  • 2.4 Prothya Biosolutions
    • 2.4.1 Prothya Biosolutions Details
    • 2.4.2 Prothya Biosolutions Major Business
    • 2.4.3 Prothya Biosolutions Human Prothrombin Complex Concentrate Product and Services
    • 2.4.4 Prothya Biosolutions Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Prothya Biosolutions Recent Developments/Updates
  • 2.5 Takeda
    • 2.5.1 Takeda Details
    • 2.5.2 Takeda Major Business
    • 2.5.3 Takeda Human Prothrombin Complex Concentrate Product and Services
    • 2.5.4 Takeda Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Takeda Recent Developments/Updates
  • 2.6 RAAS
    • 2.6.1 RAAS Details
    • 2.6.2 RAAS Major Business
    • 2.6.3 RAAS Human Prothrombin Complex Concentrate Product and Services
    • 2.6.4 RAAS Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 RAAS Recent Developments/Updates
  • 2.7 Hualan Bio
    • 2.7.1 Hualan Bio Details
    • 2.7.2 Hualan Bio Major Business
    • 2.7.3 Hualan Bio Human Prothrombin Complex Concentrate Product and Services
    • 2.7.4 Hualan Bio Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hualan Bio Recent Developments/Updates
  • 2.8 BOHUI
    • 2.8.1 BOHUI Details
    • 2.8.2 BOHUI Major Business
    • 2.8.3 BOHUI Human Prothrombin Complex Concentrate Product and Services
    • 2.8.4 BOHUI Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BOHUI Recent Developments/Updates
  • 2.9 NUOYI BIO
    • 2.9.1 NUOYI BIO Details
    • 2.9.2 NUOYI BIO Major Business
    • 2.9.3 NUOYI BIO Human Prothrombin Complex Concentrate Product and Services
    • 2.9.4 NUOYI BIO Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 NUOYI BIO Recent Developments/Updates
  • 2.10 SINOPHARM
    • 2.10.1 SINOPHARM Details
    • 2.10.2 SINOPHARM Major Business
    • 2.10.3 SINOPHARM Human Prothrombin Complex Concentrate Product and Services
    • 2.10.4 SINOPHARM Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 SINOPHARM Recent Developments/Updates
  • 2.11 Guangdong Weilun
    • 2.11.1 Guangdong Weilun Details
    • 2.11.2 Guangdong Weilun Major Business
    • 2.11.3 Guangdong Weilun Human Prothrombin Complex Concentrate Product and Services
    • 2.11.4 Guangdong Weilun Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Guangdong Weilun Recent Developments/Updates
  • 2.12 Weiguang Bio
    • 2.12.1 Weiguang Bio Details
    • 2.12.2 Weiguang Bio Major Business
    • 2.12.3 Weiguang Bio Human Prothrombin Complex Concentrate Product and Services
    • 2.12.4 Weiguang Bio Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Weiguang Bio Recent Developments/Updates
  • 2.13 Kangbo Bio
    • 2.13.1 Kangbo Bio Details
    • 2.13.2 Kangbo Bio Major Business
    • 2.13.3 Kangbo Bio Human Prothrombin Complex Concentrate Product and Services
    • 2.13.4 Kangbo Bio Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Kangbo Bio Recent Developments/Updates
  • 2.14 Huarun Boya
    • 2.14.1 Huarun Boya Details
    • 2.14.2 Huarun Boya Major Business
    • 2.14.3 Huarun Boya Human Prothrombin Complex Concentrate Product and Services
    • 2.14.4 Huarun Boya Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Huarun Boya Recent Developments/Updates
  • 2.15 Taibang Biologic
    • 2.15.1 Taibang Biologic Details
    • 2.15.2 Taibang Biologic Major Business
    • 2.15.3 Taibang Biologic Human Prothrombin Complex Concentrate Product and Services
    • 2.15.4 Taibang Biologic Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Taibang Biologic Recent Developments/Updates

3 Competitive Environment: Human Prothrombin Complex Concentrate by Manufacturer

  • 3.1 Global Human Prothrombin Complex Concentrate Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Human Prothrombin Complex Concentrate Revenue by Manufacturer (2021-2026)
  • 3.3 Global Human Prothrombin Complex Concentrate Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Human Prothrombin Complex Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Human Prothrombin Complex Concentrate Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Human Prothrombin Complex Concentrate Manufacturer Market Share in 2025
  • 3.5 Human Prothrombin Complex Concentrate Market: Overall Company Footprint Analysis
    • 3.5.1 Human Prothrombin Complex Concentrate Market: Region Footprint
    • 3.5.2 Human Prothrombin Complex Concentrate Market: Company Product Type Footprint
    • 3.5.3 Human Prothrombin Complex Concentrate Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Prothrombin Complex Concentrate Market Size by Region
    • 4.1.1 Global Human Prothrombin Complex Concentrate Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Human Prothrombin Complex Concentrate Consumption Value by Region (2021-2032)
    • 4.1.3 Global Human Prothrombin Complex Concentrate Average Price by Region (2021-2032)
  • 4.2 North America Human Prothrombin Complex Concentrate Consumption Value (2021-2032)
  • 4.3 Europe Human Prothrombin Complex Concentrate Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Human Prothrombin Complex Concentrate Consumption Value (2021-2032)
  • 4.5 South America Human Prothrombin Complex Concentrate Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Human Prothrombin Complex Concentrate Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Human Prothrombin Complex Concentrate Sales Quantity by Type (2021-2032)
  • 5.2 Global Human Prothrombin Complex Concentrate Consumption Value by Type (2021-2032)
  • 5.3 Global Human Prothrombin Complex Concentrate Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Human Prothrombin Complex Concentrate Sales Quantity by Application (2021-2032)
  • 6.2 Global Human Prothrombin Complex Concentrate Consumption Value by Application (2021-2032)
  • 6.3 Global Human Prothrombin Complex Concentrate Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Human Prothrombin Complex Concentrate Sales Quantity by Type (2021-2032)
  • 7.2 North America Human Prothrombin Complex Concentrate Sales Quantity by Application (2021-2032)
  • 7.3 North America Human Prothrombin Complex Concentrate Market Size by Country
    • 7.3.1 North America Human Prothrombin Complex Concentrate Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Human Prothrombin Complex Concentrate Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Human Prothrombin Complex Concentrate Sales Quantity by Type (2021-2032)
  • 8.2 Europe Human Prothrombin Complex Concentrate Sales Quantity by Application (2021-2032)
  • 8.3 Europe Human Prothrombin Complex Concentrate Market Size by Country
    • 8.3.1 Europe Human Prothrombin Complex Concentrate Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Human Prothrombin Complex Concentrate Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Human Prothrombin Complex Concentrate Market Size by Region
    • 9.3.1 Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Human Prothrombin Complex Concentrate Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Human Prothrombin Complex Concentrate Sales Quantity by Type (2021-2032)
  • 10.2 South America Human Prothrombin Complex Concentrate Sales Quantity by Application (2021-2032)
  • 10.3 South America Human Prothrombin Complex Concentrate Market Size by Country
    • 10.3.1 South America Human Prothrombin Complex Concentrate Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Human Prothrombin Complex Concentrate Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Human Prothrombin Complex Concentrate Market Size by Country
    • 11.3.1 Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Human Prothrombin Complex Concentrate Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Human Prothrombin Complex Concentrate Market Drivers
  • 12.2 Human Prothrombin Complex Concentrate Market Restraints
  • 12.3 Human Prothrombin Complex Concentrate Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Prothrombin Complex Concentrate and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Prothrombin Complex Concentrate
  • 13.3 Human Prothrombin Complex Concentrate Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Prothrombin Complex Concentrate Typical Distributors
  • 14.3 Human Prothrombin Complex Concentrate Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Prothrombin Complex Concentrate market size was valued at US$ 1510 million in 2025 and is forecast to a readjusted size of US$ 2944 million by 2032 with a CAGR of 10.1% during review period.
    Human prothrombin complex concentrate, also known as factor IX complex, is a plasma-derived coagulation factor extract, which was originally used to treat factor IX deficiency, because PCC also contains coagulation factors II, VII, and X, so PCCs are more commonly used Recommended for correcting coagulation abnormalities caused by warfarin. It is mainly used for the treatment of congenital and acquired coagulation factor II, VII, IX, and X deficiency (single or combined deficiency).In 2024, global Human prothrombin complex concentrate production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.
    The global market for Human Prothrombin Complex Concentrate is primarily driven by the expansion of clinical applications for plasma-derived products, heightened awareness of severe bleeding management, and the growing need for anticoagulant reversal therapy. With an aging population and increased use of anticoagulants, demand for rapid and safe hemostatic solutions continues to rise. Increased investments in trauma care systems and perioperative bleeding management for cardiovascular and hepatic patients across various countries are expanding the market potential for PCC products. Meanwhile, advances in recombinant technology and viral inactivation processes have enhanced product safety and accessibility, further propelling global market growth.
    The development of the PCC market remains constrained by the limited availability of plasma resources, the complexity of production processes, and stringent regulatory requirements. Imbalances in plasma collection systems lead to supply chain instability, while manufacturing involves multiple high-precision steps such as viral inactivation, purification, and lyophilization, requiring significant technological expertise and cost investment. Differences in regulatory approval pathways, ethical standards, and drug traceability systems across countries may further delay product commercialization. Additionally, the emergence of recombinant clotting factors and synthetic hemostatic substitutes poses potential competition in specific clinical applications, raising the bar for innovation and compliance among traditional PCC manufacturers.
    Downstream demand for PCC primarily originates from hospital emergency departments, intensive care units, and surgical applications. With the increasing volume of cardiovascular interventions, hepatobiliary surgeries, and trauma procedures, clinical use of PCC continues to expand. Reversal of anticoagulant-induced bleeding, particularly from warfarin therapy, has become one of its main use cases. Moreover, PCC usage is growing steadily in emergency and perioperative coagulation management. In developing regions, accessibility to plasma-derived products is improving, leading to rising import and local production demand for PCC, alongside a diffusion trend from tertiary hospitals to regional medical institutions.
    The primary upstream raw material for PCC production is high-quality human plasma, whose stable supply is essential for maintaining industry competitiveness. Plasma must undergo rigorous screening, separation, and viral inactivation processes, and instability at any stage can impact product yield and safety. Global plasma collection is concentrated among a few major suppliers, and regional regulatory variations may lead to uneven supply. In addition to plasma, the production process requires auxiliary materials such as chromatographic resins, filtration membranes, and lyoprotectants, whose purity and batch consistency are critical for quality assurance. As the industry moves toward higher purity and safety standards, manufacturers are increasingly strengthening raw material traceability and consistency management across the supply chain.
    This report is a detailed and comprehensive analysis for global Human Prothrombin Complex Concentrate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Prothrombin Complex Concentrate market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Prothrombin Complex Concentrate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Prothrombin Complex Concentrate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Prothrombin Complex Concentrate market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Prothrombin Complex Concentrate
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Prothrombin Complex Concentrate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, RAAS, Hualan Bio, BOHUI, NUOYI BIO, SINOPHARM, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human Prothrombin Complex Concentrate market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Beriplex
    Profilnine
    Octaplex
    Prothromplex
    Cofact
    Other
    Market segment by Composition
    3-Factor PCC
    4-Factor PCC
    Recombinant Coagulation Complex
    Other
    Market segment by Manufacturing Process
    Plasma-Derived
    Recombinant Bioengineered
    Market segment by Application
    Hemophilia B
    Vitamin K Deficiency
    Other
    Major players covered
    CSL Behring
    Grifols
    Octapharma
    Prothya Biosolutions
    Takeda
    RAAS
    Hualan Bio
    BOHUI
    NUOYI BIO
    SINOPHARM
    Guangdong Weilun
    Weiguang Bio
    Kangbo Bio
    Huarun Boya
    Taibang Biologic
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human Prothrombin Complex Concentrate product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human Prothrombin Complex Concentrate, with price, sales quantity, revenue, and global market share of Human Prothrombin Complex Concentrate from 2021 to 2026.
    Chapter 3, the Human Prothrombin Complex Concentrate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human Prothrombin Complex Concentrate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human Prothrombin Complex Concentrate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human Prothrombin Complex Concentrate.
    Chapter 14 and 15, to describe Human Prothrombin Complex Concentrate sales channel, distributors, customers, research findings and conclusion.

    Buy now